Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial
Phase 1
Recruiting
- Conditions
- Intracranial AneurysmSubarachnoid Hemorrhage
- Interventions
- Other: placebo
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02875262
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
🇳🇱University Medical Center Groningen, Groningen, Netherlands
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
Phase 2
- Conditions
- Hereditary Hemorrhagic TelangiectasiaGastrointestinal HemorrhageAnemia
- Interventions
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT02874326
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
🇳🇱St Antonius Hospital, Nieuwegein, Utrecht, Netherlands
Intra-peritoneal Chemotherapy in Ovarian Cancer
- Conditions
- Ovarian NeoplasmsEffects of ChemotherapyNeoplasmsImmune Tolerance
- First Posted Date
- 2016-08-10
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT02861872
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery
Phase 4
Completed
- Conditions
- Renal Transplant Donor of Left KidneyNeuromuscular BlockRenal Transplant Donor of Right KidneySurgery
- Interventions
- Other: No additional RocuroniumOther: Rocuronium
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 101
- Registration Number
- NCT02838134
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
🇳🇱LUMC, Leiden, Netherlands
Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: malaria challenge infection, P. falciparum 3D7Drug: Atovaquone-proguanil
- First Posted Date
- 2016-07-18
- Last Posted Date
- 2018-03-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT02836002
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands
Effect of Statins on Trained Immunity
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT02817230
- Locations
- 🇳🇱
Erasmus Medical Center, Rotterdam, Netherlands
🇳🇱Academic Medical Center, Amsterdam, Netherlands
🇳🇱Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Compliance With Hand Hygiene in Nursing Homes: Go for a Sustainable Effect (CHANGE)
Not Applicable
Completed
- Conditions
- Infectious and Communicable Diseases
- Interventions
- Other: Hand hygiene implementation strategy
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02817282
Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)
Completed
- Conditions
- Breast CancerRenal Cell Carcinoma
- First Posted Date
- 2016-06-22
- Last Posted Date
- 2017-10-16
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT02809404
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Netherlands
Improving Quality of Care for Patients With Recurrent Ovarian Cancer
- Conditions
- Ovarian NeoplasmsQuality of Life
- Interventions
- Other: Questionnaires
- First Posted Date
- 2016-06-22
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 360
- Registration Number
- NCT02809339
Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections
Phase 4
Completed
- Conditions
- Acute Myeloid LeucaemiaMyelo Dysplastic SyndromeAllogeneic Stem Cell TransplantAcute Graft Versus Host Disease
- Interventions
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2019-12-16
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT02805946
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
🇧🇪Universitaire Ziekenhuizen Leuven, Leuven, Belgium
© Copyright 2025. All Rights Reserved by MedPath